The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Conference item |
| Language: | English |
| Published: |
Elsevier
2020
|